DUARTE, Calif.–(BUSINESS WIRE)–City of Hope announces Phase 2 study results showing sotorasib can shrink tumors and has minimal side effects for advanced colorectal cancer patients.
DUARTE, Calif.–(BUSINESS WIRE)–City of Hope announces Phase 2 study results showing sotorasib can shrink tumors and has minimal side effects for advanced colorectal cancer patients.
Copyright © 2026 Biotech Networks, LLC